Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
ITCC-P4 gGmbH
Homepage:
itccp4.com
ROR:
03z4agd71
OpenAlex ID:
I4405260571
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology
2026
·
Marlinde C. Schoonbeek
, Pierre Gestraud
, et al.
·
npj Precision Oncology
·
6
PDF
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
·
Cancer Research
·
3
Sensitivity profiling reveals consistent drug responses across preclinical neuroblastoma models
2026
·
Marlinde. C. Schoonbeek
, Marloes van Luik
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Abstract B012: In vivo Mini screen to assess the Antitumor Effect of Carboxyamidotriazole orotate (CTO) and temozolomide (TMZ) in Monotherapy in Three ITCC-P4’s High-grade Glioma (HGG) Pediatric Patient Derived Xenograft (PDX) Tumor Models
2026
·
Rashida A. Karmali
, Romina Walter
, et al.
·
Cancer Research
MicroOrganoSphere™ technology to advance drug screening in neuroblastoma precision medicine
2026
·
Marlinde C. Schoonbeek
, Vicky Amo-Addae
, et al.
·
EJC Paediatric Oncology
PDF
Abstract 840: The ITCC-P4 consortium: Deep molecular characterization of pediatric cancer xenograft (PDX) models enable prediction of novel personalized combination treatment options for patients with childhood cancer
2025
·
Dennis Gürgen
, Apurva Gopisetty
, et al.
·
Cancer Research
Abstract 1202: Molecular profiles and drug response of ITCC-P4 patient-derived xenograft pediatric cancer models for target identification and prediction of targeted therapies
2025
·
Dennis Gürgen
, Apurva Gopisetty
, et al.
·
Cancer Research
Abstract 5469: ITCC-P4, a preclinical proof-of-concept drug testing platform as a tool for pharmacological screening in pediatric tumor models
2024
·
Emilie Indersie
, Sophie Branchereau
, et al.
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
47
Year
Topic
Type